Nucleic acid nanomedicines in Phase II/III clinical trials: translation of nucleic acid therapies for reprogramming cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nucleic acid nanomedicines in Phase II/III clinical trials: translation of nucleic acid therapies for reprogramming cells

Published:2018-08 Issue:16 Volume:13 Page:2083-2098
ISSN:1743-5889
Container-title:Nanomedicine
language:en
Short-container-title:Nanomedicine

Author:

Herrera Victoria LM¹²,Colby Aaron H³,Ruiz-Opazo Nelson¹²,Coleman David G¹,Grinstaff Mark W¹³⁴

Affiliation:

1. Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA

2. Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA

3. Department of Biomedical Engineering, Boston University, Boston, MA 02215, USA

4. Department of Chemistry, Boston University, Boston, MA 02215, USA

Publisher

Future Medicine Ltd

Subject

Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://www.futuremedicine.com/doi/pdf/10.2217/nnm-2018-0122

Reference34 articles.

1. Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy

2. Nucleic Acids Delivery Systems: A Challenge for Pharmaceutical Technologists

3. Synthetic Nucleic Acid Delivery Systems: Present and Perspectives

4. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

5. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Branching in poly(amine-co-ester) polyplexes impacts mRNA transfection;Biomaterials;2024-12

2. Atypical artificial cells: Novel biomimetic materials for combating cancer;Interdisciplinary Materials;2024-07-17

3. In Silico Screening Accelerates Nanocarrier Design for Efficient mRNA Delivery;Advanced Science;2024-06-05

4. Recent Progress of Small Interfering RNA Delivery on the Market and Clinical Stage;Molecular Pharmaceutics;2024-04-17

5. Tuning CpG motif position in nanostructured DNA for efficient immune stimulation;Biotechnology Journal;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3